"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
Systemic consequences associated with overdosage of MAGNEVIST Injection have not been reported.
MAGNEVIST is contraindicated in patients with:
- Chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
- Acute kidney injury.
Last reviewed on RxList: 4/11/2012
Additional Magnevist Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.